Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer

  • STATUS
    Recruiting
  • End date
    Aug 21, 2023
  • participants needed
    2240
  • sponsor
    Gustave Roussy, Cancer Campus, Grand Paris
Updated on 21 January 2021
cancer
metastasis
tumor cells
solid tumor
targeted therapy
metastatic solid tumor

Summary

Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.

Details
Condition Metastasis, Liver Metastases, Bone Metastases, Brain Metastases, Cancer, Metastatic, Metastatic Cancer, Neoplasm Metastasis, cancers metastatic, metastases, metastatic disease, secondary cancer, secondaries, metastatic tumor, metastasized
Treatment blood samples
Clinical Study IdentifierNCT02666612
SponsorGustave Roussy, Cancer Campus, Grand Paris
Last Modified on21 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients with metastatic solid tumor
Age> 18 years
Signed consent

Exclusion Criteria

Patients with diseases associated with vascular lesions known
Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the Code of Public Health
Mental pathology that can interfere with the proper conduct of the study
Refusal of consent
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note